Condition
Calprotectin
Total Trials
6
Recruiting
1
Active
1
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 5 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed5
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07524153Completed
Diode Laser and S100A8 in Peri-Implantitis
NCT04835727Not ApplicableCompleted
Effect of Semi-vegetarian Diet in Inflammatory Bowel Disease Patients With Clinical Remission
NCT04973423Not ApplicableRecruiting
STUDY OF THE ADDED VALUE OF A TRANSMURAL EVALUATION IN PATIENTS WITH CROHN'S DISEASE UNDER BIOTHERAPY WITH CLOSE FECAL CALPROTECTIN FOLLOW-UP
NCT03255564CompletedPrimary
Monitor Faecal Calprotectin Concentration in Infants With Heart Defects
NCT04491799Completed
Fecal Calprotectin Level in Patients With Nosocomial Diarrhea
NCT00577928CompletedPrimary
Value of Fecal Calprotectin
Showing all 6 trials